home0005 - Dr. Zheng-Li Shi (born 1964)

Shi Zhengli (simplified Chinese: 石正丽; traditional Chinese: 石正麗; born 26 May 1964) is a Chinese virologist who researches SARS-like coronaviruses of bat origin. Shi directs the Center for Emerging Infectious Diseases at the Wuhan Institute of Virology (WIV). In 2017, Shi and her colleague Cui Jie discovered that the SARS coronavirus likely originated in a population of cave-dwelling horseshoe bats in Xiyang Yi Ethnic Township, Yunnan.^[1] She came to prominence in the popular press as "Batwoman" during the COVID-19 pandemic for her work with bat coronaviruses.^[2] Shi was included in Time's 100 Most Influential People of 2020.^[3]

Early life and education

Shi was born in May 1964 in Xixia County, Henan.^[4] She graduated from Wuhan University in 1987 with a bachelor's degree in genetics.^[5] She received her master's degree from the Wuhan Institute of Virology of the Chinese Academy of Sciences (CAS) in 1990, and she received her PhD at the Montpellier 2 University in France in 2000, where she gained fluency in French.^[6][7]

Career

In 2005, Shi Zhengli and colleagues found that bats are the natural reservoir of SARS-like coronaviruses.^[8][9][10] In 2008, Shi led a research team which studied binding of spike proteins of both natural and chimaeric SARS-like coronaviruses to ACE2 receptors in human, civet and horseshoe bat cells, to determine the mechanism by which SARS may have spilled over into humans.^[11][12] In 2015, Shi Zhengli published a paper led by Ralph S Baric of the University of North Carolina, which showed that that SARS had the potential to re-emerge from coronaviruses circulating in bat populations in the wild.^[13] Shi and her colleague Cui Jie led a team which sampled thousands of horseshoe bats throughout China. In 2017, they published their findings, indicating that all the genetic components of the SARS coronavirus existed in a bat population in Xiyang Yi Ethnic Township, Yunnan.^[1] While no single bat harbored the exact strain of virus which caused the 2002–2004 SARS outbreak, genetic analysis showed that different strains often mix, suggesting that the human version likely emerged from a combination of the strains present in the bat population.^[1] Shi's discoveries on the origin of SARS earned her international recognition.^[14]

Shi is the director of the Center for Emerging Infectious Diseases at the Wuhan Institute of Virology (WIV), located in Jiangxia District, Wuhan.^[15] On her resume, Shi mentioned receiving grant funding from U.S. government sources totaling more than US$1.2 million, including $665,000 from the National Institutes of Health from 2014 to 2019, as well as US$559,500 over the same period from USAID.^[16]

2020

During the COVID-19 pandemic, Shi and other institute scientists formed an expert group to research Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).^[17][18] In February 2020, researchers led by Shi Zhengli published an article in Nature titled, "A pneumonia outbreak associated with a new coronavirus of probable bat origin", finding that SARS-CoV-2 is in the same family as SARS, and that it has 96.2% genome overlap with the most closely related known coronavirus, RaTG13.^[19] In February 2020, her team published a paper in Cell Research showing that remdesivir and chloroquine inhibited the virus in vitro, and applied for a patent for the drug in China on behalf of the WIV.^[20][21][22] This caused conflict with an American pharmaceutical firm that had also applied for a patent.^[23] Shi co-authored a paper labelling the virus as the first Disease X.^[24]
In February 2020, the South China Morning Post reported that Shi's decade-long work to build up one of the world's largest databases of bat-related viruses gave the scientific community a "head start" in understanding the virus.^[25] The SCMP also reported that Shi was the focus of personal attacks in Chinese social media who claimed the WIV was the source of the virus, leading Shi to strongly affirm that the outbreak "has nothing to do with the lab."^[25] In a March 2020 interview with Scientific American, where she was called China's "Bat Woman",^[26] Shi said "Bat-borne coronaviruses will cause more outbreaks", and "We must find them before they find us."^[2] In June 2021 the New York Times said that her research on coronaviruses at a state lab in Wuhan, had put her at the center of an outburst of feelings regarding the pandemic.^[27] Leading virologists have explained that SARS-CoV-2 is most likely of natural origin, and that it is extremely unlikely that it leaked from a lab.^[28][29] Shi's colleague Peter Daszak of the EcoHealth Alliance,^[30] which studies emerging infectious diseases, has noted estimates that 1–7 million people in Southeast Asia who live or work in proximity to bats are infected each year with bat coronaviruses.^[28][29] On July 31 Science Magazine published an interview with Shi in which she commented "to date, there is zero infection of all staff and students in our institute."^[31] Asked by Science why the WIV conducts coronavirus experiments in BSL-4 labs when most other scientists work with coronaviruses BSL-2 or BSL-3 conditions, Shi explained that her group also used BSL-2 and BSL-3 laboratories for their coronavirus research, but that they had begun to use BSL-4 laboratories per government regulations after the pandemic.^[32][33][31]

Service and honours

Shi is a member of the Virology Committee of the Chinese Society for Microbiology. She is editor-in-chief of Virologica Sinica,^[34] the Chinese Journal of Virology, and the Journal of Fishery Sciences of China.

2016 Chevalier of the Ordre des Palmes académiques^[35]
2018 State Natural Science Award (Second Class)^[36]
February 2019 Fellow of the American Academy of Microbiology (AAM)^[37]

References

For the research paper, see: Wang, Ning (2018). "Serological Evidence of Bat SARS-Related Coronavirus Infection in Humans, China" (PDF). Virologica Sinica. 33 (1): 104–107. doi:10.1007/s12250-018-0012-7. PMC 6178078. PMID 29500691.
For English news coverage, see: "Bat cave solves mystery of deadly SARS virus — and suggests new outbreak could occur". Nature. 1 December 2017.
For a more detailed news coverage in Chinese, see: "石正丽团队两年前已发现蝙蝠冠状病毒感染人现象". The Beijing News [新京报]. 26 February 2020.
^a ^b Qiu, Jane (11 March 2020). "How China's "Bat Woman" Hunted Down Viruses from SARS to the New Coronavirus". Scientific American. Archived from the original on 14 April 2020. Retrieved 13 April 2020.
^ "Shi Zhengli: The 100 Most Influential People of 2020". Time. Retrieved 23 September 2020.
^ 石正丽：与病毒相伴的女科学家. sciencenet.cn (in Chinese (China)). 10 March 2009. Archived from the original on 7 February 2019. Retrieved 6 February 2019. 1964年5月，石正丽出生于河南省西峡县。
^ 中科院武汉病毒所博士生指导老师简介 (in Chinese (China)). Chinese Academy of Sciences, Wuhan Division. 22 September 2009. Archived from the original on 10 August 2018. 石正丽, 女， 1964年出生，博士，研究员。1987年7月毕业于武汉大学生物系遗传专业，获学士学位。
^ Areddy, James T. (21 April 2020). "China Bat Expert Says Her Wuhan Lab Wasn't Source of New Coronavirus". The Wall Street Journal. Archived from the original on 23 April 2020. Retrieved 27 April 2020.
^ Zaugg, Julie (22 January 2021). "A Wuhan avec Bat Woman, aux origines du Covid-19". L'illustré (in French).
^ Li, Wendong; Shi, Zhengli; Yu, Meng; Ren, Wuze; Smith, Craig; Epstein, Jonathan H; Wang, Hanzhong; Crameri, Gary; Hu, Zhihong; Zhang, Huajun; Zhang, Jianhong; McEachern, Jennifer; Field, Hume; Daszak, Peter; Eaton, Bryan T; Zhang, Shuyi; Wang, Lin-Fa (28 October 2005). "Bats Are Natural Reservoirs of SARS-Like Coronaviruses". Science. 310 (5748): 676–679. Bibcode:2005Sci...310..676L. doi:10.1126/science.1118391. PMID 16195424. S2CID 2971923.
^ Lu Wei (鲁伟); Liu Zheng (刘铮) (10 March 2009). 石正丽：与病毒相伴的女科学家. sciencenet.cn (in Chinese). Archived from the original on 7 February 2019. Retrieved 26 January 2020.
^ Ren, Wuze; Li, Wendong; Yu, Meng; Hao, Pei; Zhang, Yuan; Zhou, Peng; Zhang, Shuyi; Zhao, Guoping; Zhong, Yang; Wang, Shengyue; Wang, Lin-Fa; Shi, Zhengli (1 November 2006). "Full-length genome sequences of two SARS-like coronaviruses in horseshoe bats and genetic variation analysis". J Gen Virol. 87 (11): 3355–3359. doi:10.1099/vir.0.82220-0. PMID 17030870.
^ Ren, Wuze; et al. (1 February 2008). "Difference in Receptor Usage between Severe Acute Respiratory Syndrome (SARS) Coronavirus and SARS-Like Coronavirus of Bat Origin". Journal of Virology. 82 (4): 1899–1907. doi:10.1128/JVI.01085-07. PMC 2258702. PMID 18077725.
^ Hou, Yuxuan; et al. (22 June 2010). "Angiotensin-converting enzyme 2 (ACE2) proteins of different bat species confer variable susceptibility to SARS-CoV entry". Archives of Virology. 155 (10): 1563–1569. doi:10.1007/s00705-010-0729-6. PMC 7086629. PMID 20567988.
^ Menachery, Vineet D.; Yount, Boyd L.; Debbink, Kari; Agnihothram, Sudhakar; Gralinski, Lisa E.; Plante, Jessica A.; Graham, Rachel L.; Scobey, Trevor; Ge, Xing-Yi; Donaldson, Eric F.; Randell, Scott H. (11 November 2015). "A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence". Nature Medicine. 21 (12): 1508–1513. doi:10.1038/nm.3985. ISSN 1546-170X. PMC 4797993. PMID 26552008.
^ Sudworth, John (21 December 2020). "Covid: Wuhan scientist would 'welcome' visit probing lab leak theory". BBC News. Retrieved 6 September 2021.
^ "Prof. Shi Zhengli elected a fellow of the American Academy of Microbiology". 8 March 2019. Retrieved 31 December 2020.
^ "The Lab-Leak Theory: Inside the Fight to Uncover COVID-19's Origins". Vanity Fair. 3 June 2021.
^ Zhang Juan (张隽); Guan Xiyan (关喜艳) (24 January 2020). 石正丽等13位专家组队攻关新型肺炎研究. People's Daily (in Chinese). Retrieved 26 January 2020.
^ Cohen, Jon (1 February 2020). "Mining coronavirus genomes for clues to the outbreak's origins". Science. Archived from the original on 3 February 2020. Retrieved 4 February 2020. team led by Shi Zheng-Li, a coronavirus specialist at the Wuhan Institute of Virology, reported on 23 January on bioRxiv that 2019-nCoV’s sequence was 96.2% similar to a bat virus and had 79.5% similarity to the coronavirus that causes severe acute respiratory syndrome (SARS), a disease whose initial outbreak was also in China more than 15 years ago.
^ Zhengli, Shi; Team of 29 researchers at the WIV (3 February 2020). "A pneumonia outbreak associated with a new coronavirus of probable bat origin". Nature. 579 (7798): 270–273. Bibcode:2020Natur.579..270Z. doi:10.1038/s41586-020-2012-7. PMC 7095418. PMID 32015507.
^ Zhengli, Shi; Team of 10 researchers at the WIV (4 February 2020). "Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro". Cell Research. 30 (3): 269–271. doi:10.1038/s41422-020-0282-0. PMC 7054408. PMID 32020029.
^ "China Wants to Patent Gilead's Experimental Coronavirus Drug". Bloomberg News. Archived from the original on 6 February 2020. Retrieved 5 February 2020.
^ Grady, Denise (6 February 2020). "China Begins Testing an Antiviral Drug in Coronavirus Patients". The New York Times. Archived from the original on 8 February 2020. Retrieved 8 February 2020.
^ Barmann J. "Bay Area-Based Gilead Sees Potential Legal Conflict With China Over Its Coronavirus Drug". SFist. Impress Media. Archived from the original on 26 March 2020. Retrieved 22 March 2020.
^ Zhengli, Shi; Shibo, Jiang (2020). "The First Disease X is Caused by a Highly Transmissible Acute Respiratory Syndrome Coronavirus". Virologica Sinica. 35 (3): 263–265. doi:10.1007/s12250-020-00206-5. PMC 7091198. PMID 32060789.
^a ^b Chen, Stephen (6 February 2020). "Coronavirus: bat scientist's cave exploits offer hope to beat virus 'sneakier than Sars'". South China Morning Post. Archived from the original on 7 February 2020. Retrieved 8 February 2020.
^ Cohen, Jon (24 July 2020). "'Trump owes us an apology.' Chinese scientist at the center of COVID-19 origin theories speaks out". Science. doi:10.1126/science.abd9835.
^ Qin, Amy; Buckley, Chris (14 June 2021). "A Top Virologist in China, at Center of a Pandemic Storm, Speaks Out". The New York Times.
^a ^b Brumfiel, Geoff; Kwong, Emily (23 April 2020). "Virus Researchers Cast Doubt On Theory Of Coronavirus Lab Accident". Archived from the original on 28 April 2020. Retrieved 29 April 2020.
^a ^b Barclay, Eliza (23 April 2020). "Why these scientists still doubt the coronavirus leaked from a Chinese lab". Vox Media. Archived from the original on 30 April 2020. Retrieved 29 April 2020.
^ Subbaraman, Nidhi (2020). "'Heinous!': Coronavirus researcher shut down for Wuhan-lab link slams new funding restrictions". Nature. doi:10.1038/d41586-020-02473-4. Retrieved 22 May 2021.
^a ^b "Reply to Science Magazine" (PDF). Science Magazine. Retrieved 7 December 2021.
^ Cohen, Jon (31 July 2020). "Wuhan coronavirus hunter Shi Zhengli speaks out". Science Magazine. 369 (6503): 487–488. Bibcode:2020Sci...369..487C. doi:10.1126/science.369.6503.487. PMID 32732399. Retrieved 26 May 2021.
^ Kessler, Glenn (25 May 2021). "Timeline: How the Wuhan lab-leak theory suddenly became credible". The Washington Post. Retrieved 25 May 2021.
^ "Editorial Board". Virologica Sinica. Archived from the original on 29 February 2020. Retrieved 10 March 2020.
^ 法国驻华大使亲临武汉病毒所为袁志明、石正丽研究员授勋 (in Chinese). Wuhan Institute of Virology. 20 June 2016.
^ Huang Haihua (黄海华) (24 January 2020). 新型冠状病毒可能来源于蝙蝠！"蝙蝠女侠"石正丽发现其与蝙蝠冠状病毒同源性为96% (in Chinese). Sina Corp. Retrieved 26 January 2020.
^ 学界大牛！12位华人学者当选2019年美国微生物科学院院士. xincailiao.com (in Chinese). 3 February 2019. Archived from the original on 7 February 2019. Retrieved 6 February 2019.

External links

Wikiquote has quotations related to: Shi Zhengli

Profile: Shi Zhengli, from the World Society of Virology
Profile: Shi Zhengli, from the Wuhan Institute of Virology (in Chinese)

Zheng-Li Shi

Virological Sinica

Al isues - https://www.ncbi.nlm.nih.gov/labs/pmc/journals/3534/

https://www.scimagojr.com/journalsearch.php?q=4000149402&tip=sid

"Virologica Sinica is an international journal which aims at presenting the cutting-edge research on viruses all over the world. The journal publishes peer-reviewed original research articles, reviews, and letters to the editor, to encompass the latest developments in all branches of virology, including research on animal, plant and microbe viruses. The journal welcomes articles on virus discovery and characterization, viral epidemiology, viral pathogenesis, virus-host interaction, vaccine development, antiviral agents and therapies, and virus related bio-techniques. Virologica Sinica, the official journal of Chinese Society for Microbiology, will serve as a platform for the communication and exchange of academic information and ideas in an international context. Electronic ISSN: 1995-820X; Print ISSN: 1674-0769"

https://www.keaipublishing.com/en/journals/virologica-sinica/editorial-board/

2022-02-www-keaipublishing-english-journals-viologica-sinica-editorial-board.pdf

2022-02-www-keaipublishing-english-journals-viologica-sinica-editorial-board-img-1.jpg

....

Prof. Xiangguo QiuNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada...Prof. George F. GaoNational Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing China; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China...Prof. George F. GaoNational Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing China; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China...Prof. Sina BavariEdge BioInnovation and Healion Bio, Frederick, MD, USA...
Prof. Jens KuhnVirology Lead, National Institute of Allergy and Infectious Diseases, NIH, USA....

Editorial Board
ISSN: 1995-820XEditor-in-Chief
Prof. Zheng-Li ShiCAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, China
Email Prof. Zheng-Li Shi
Advisory BoardProf. Hualan ChenState Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, CAAS, China
Prof. Xinwen ChenGuangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China
Prof. George F. GaoNational Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing China; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China
Prof. Xinyuan LiuLaboratory of Molecular Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institute for Biological Sciences, Chinese Academy of Sciences, Shanghai, China.
Prof. Hong-Bing ShuMedical Research Institute, Wuhan University, Wuhan, China
Prof. Fu-Sheng WangDepartment of Infectious Diseases, Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, China
Prof. Linfa WangProgramme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, Singapore
Prof. Yumei WenKey Laboratory of Medical Molecular Virology, Fudan University, Shanghai, China
Prof. Jianguo XuState Key Laboratory of Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
Prof. Kwok-Yung YuenDepartment of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China
Associate EditorsProf. Basil M. ArifGreat Lakes Forestry Centre, Canadian Forest Service Sault Ste. Marie, Ontario, Canada
Prof. Prof. Dimiter DimitrovCenter for Antibody Therapeutics, University of Pittsburgh Medical School, Pittsburgh, USA
Prof. Xia JinShanghai Public Health Clinical Center, Fudan University, Shanghai, China
Prof. Ke LanState Key Laboratory of Virology, College of Life Sciences, Medical Research Institute, Wuhan University, Wuhan, China
Prof. Yi LiThe State Key Laboratory of Protein and Plant Gene Research, School of Life Sciences, Peking University, Beijing, China
Prof. Mengji LuInstitute of Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
Prof. Wenjun MaDepartment of Diagnostic Medicine/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, USA
Prof. Pei-Yong ShiDepartment of Biochemistry and Molecular Biology, Institute for Human Infection and Immunity, Sealy Institute for Vaccine Sciences, Sealy Center for Structural Biology & Molecular Biophysics, Department of Pharmacology & Toxicology, University of Texas Medical Branch, Galveston, USA
Prof. Yi-Wei TangClinical Microbiology Service, Memorial Sloan-Kettering Cancer Center, USA
Prof. Yan-Yi WangWuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, China
Prof. Yuntao WuNational Center for Biodefense and Infectious Diseases, School of Systems Biology, George Mason University, Manassas, USA
Prof. Xuejie YuSchool of Health Sciences, Wuhan University, Wuhan, China
Prof. Zhi-Ming ZhengTumor Virus RNA Biology Section, HIV DRP, National Cancer Institute, NIH, Frederick, MD, USA
Editorial BoardProf. Jing AnDepartment of Microbiology, School of Basic Medical Sciences, Capital Medical University, Beijing, China
Prof. Thomas BaumertInstitut National de la Santé et de la Recherche Médicale (Inserm), U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, Strasbourg, France; Université de Strasbourg, Strasbourg, France; Institut Hospitalo-Universitaire, Pôle Hépato-digestif, Nouvel Hôpital Civil, Strasbourg, France
Prof. Sina BavariEdge BioInnovation and Healion Bio, Frederick, MD, USA
Prof. Lionel BerthouxDepartment of Medical Biology, Université du Québec à Trois-Rivières, Trois-Rivières, QC, Canada
Prof. Hervé BourhyInstitut Pasteur, 25-28 Rue du Dr Roux, Paris, France
Prof. Christopher C. BroderDepartment of Microbiology and Immunology, Uniformed Services University, Bethesda, MD, USA
Prof. Ling ChenState Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health (GIBH), Chinese Academy of Sciences, Guangzhou, China
Prof. Mingzhou ChenState Key Laboratory of Virology and Modern Virology Research Center, College of Life Sciences, Wuhan University, Wuhan, China.
Prof. Gong ChengTsinghua-Peking Center for Life Sciences, School of Medicine, Tsinghua University, Beijing China;
Prof. Kaw Bing ChuaTemasek Life Sciences Laboratory Limited, Singapore
Prof. Jean Michael ClaverieAix Marseille Université, CNRS, IGS, Information Génomique & Structurale (UMR7256), Institut de Microbiologie de la Méditerranée (FR 3489), Marseille, France
Prof. Jie CuiPathogen Bioinformatics Unit, Institut Pasteur of Shanghai, CAS, Shanghai, China
Prof. Fei DengState Key Laboratory of Virology and National Virus Resource Center, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China
Prof. Hongyu DengCAS Key Laboratory of Infection and Immunity, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China;
Prof. Lanying DuLindsley F. Kimball Research Institute, New York Blood Center, New York, NY, USA
Prof. Min FangCAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China
Prof. Wenhai FengState Key Laboratory of Agrobiotechnology, Department of Microbiology and Immunology, College of Biological Sciences, China Agricultural University, Beijing, China
Prof. Zhen F. FuDepartment of Pathology, College of Veterinary Medicine, University of Georgia, Athens, GA, USA
Prof. Peng GongKey Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China
Prof. Deyin GuoMOE Key Laboratory of Tropical Disease Control, Centre for Infection and Immunity Study, School of Medicine, Sun Yat-sen University, Shenzhen, China
Prof. Haitao GuoDepartment of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, USA
Prof. Jianmin HuMicrobiology and Immunology, The Pennsylvania State University, USA
Prof. Qinxue HuState Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China
Prof. Daohong JiangState Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University, Wuhan, China
Prof. Jens KuhnVirology Lead, National Institute of Allergy and Infectious Diseases, NIH, USA
Prof. Kui LiDepartment of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, Memphis, USA
Prof. Qihan LiInstitute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China
Prof. Wenhui LiNational Institute of Biological Science, Beijing, China
Prof. Zhenghe LiFaculty of Agriculture, Life and Environment Science, Institute of Biotechnology, Zhejiang University, Hongzhou, China
Prof. Di LiuNational Virus Resource Center, Chinese Academy of Sciences, Wuhan, China
Prof. Jinhua LiuKey Laboratory of Animal Epidemiology and Zoonosis, Ministry of Agriculture, College of Veterinary Medicine and State Key Laboratory of Agrobiotechnology, China Agricultural University, Beijing, China
Prof. Wenjun LiuCAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China
Prof. Shan LuDepartment of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA
Prof. Yuanan LuEnvironmental Health Laboratory, Department of Public Health Sciences, University of Hawaii at Manoa, Honolulu, USA
Prof. Guangxiang (George) LuoDepartment of Microbiology, University of Alabama at Birmingham School of Medicine, USA
Prof. Min-Hua LuoState Key Laboratory of Virology, CAS Center for Excellence in Brain Science and Intelligence Technology, Center for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China
Prof. Hinh LyDepartment of Veterinary and Biomedical Sciences, University of Minnesota, Twin Cities, St. Paul, Minnesota, USA
Prof. Chuanbin MaoDepartment of Chemistry & Biochemistry, Stephenson Life Sciences Research Center, University of Oklahoma, Norman, USA
Prof. Venugopal NairThe Pirbright Institute, Surrey, UK;
Prof. Cheng-Feng QinState Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, AMMS, Beijing, China
Prof. Xiangguo QiuNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada
Prof. Lijun RongDepartment of Microbiology and Immunology, College of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA
Prof. Charles E. SamuelDepartment of Molecular, Cellular, and Developmental Biology, University of California, Santa Barbara, USA
Prof. Sang Heui SeoLaboratory of Influenza Research, College of Veterinary Medicine, Chungnam National University, Daejeon, Republic of Korea
Prof. Donald SetoBioinformatics and Computational Biology Program, School of Systems Biology, George Mason University, Manassas, Virginia, USA
Prof. Yiming ShaoState Key Laboratory for Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, China
Prof. Weifeng ShiKey Laboratory of Etiology and Epidemiology of Emerging Infectious Diseases in Universities of Shandong, Shandong First Medical University & Shandong Academy of Medical Sciences, Taian, China
Prof. Lishan SuLineberger Comprehensive Cancer Center, Department of Microbiology and Immunology, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Prof. Ren SunDepartment of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, USA
Prof. Hengli TangDepartment of Biological Science, Florida State University, Tallahassee, USA
Prof. Yigang TongCollege of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China
Prof. Wenwei TuDepartment of Paediatrics & Adolescent Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China
Prof. Just M. VlakLaboratory of Virology, Wageningen University, Wageningen, The Netherlands
Prof. Jian-Hua WangUnit of Viral Immunology, Institute Pasteur of Shanghai, Life Science Research Building, Shanghai,China
Prof. Jianwei WangNHC Key Laboratory of Systems Biology of Pathogens and Christophe Merieux Laboratory, Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Prof. Huimin YanShanghai Public Health Clinical Center, Fudan University, Shanghai, China
Prof. Bo ZhangKey Laboratory of Special Pathogens and Biosafety, Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China
Prof. Yong-Zhen ZhangShanghai Public Health Clinical Center, State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai, China
Prof. Xin ZhengDepartment of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Prof. Bo ZhongCollege of Life Sciences, Wuhan University, Wuhan, China
Prof. Jin ZhongInstitut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China
Prof. Xi ZhouState Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China
Prof. Fanxiu ZhuDepartment of Biological Science, Florida State University, Tallahassee, Florida, USA
Managing EditorDr. Jiali SiEditorial Office of Virologica Sinica
Email Dr. Jiali Si
Editorial OfficeVirologica Sinica Editorial OfficeWuhan Institute of Virology, Chinese Academy of Sciences, China
Email Virologica Sinica Editorial Office

Page updated

Report abuse

Dr. Zheng-Li Shi (born 1964)

Wikipedia 🌐 Shi Zhengli

ASSOCIATIONS